Biology Reference
In-Depth Information
23. Buck CD, Pastrana DV, Lowy DR, Schiller JT. (2004) Efficient intra-
cellular assembly of papillomaviral vectors.
78
: 751-757.
24. Kawana K, Yoshikawa H, Taketani Y,
et al
. (1998)
In vitro
construction
of pseudovirions of human papillomavirus type 16: Incorporation of plas-
mid DNA into reassembled L1/L2 capsids.
J Virol
72
: 10298-10300.
25. Roden RBS, Kirnbauer R, Jenson AB,
et al
. (1994) Interaction of papil-
lomaviruses with the cell surface.
J Virol
68
: 7260-7266.
26. Mueller M, Gissmann L, Cristiano RJ,
et al
. (1995) Papillomavirus cap-
sid binding and uptake by cells from different tissues and species.
J Virol
69
: 948-954.
27. Volpers C, Unkell P, Schirmacher P,
et al
. (1995) Binding and internal-
ization of human papillomavirus type 33 virus-like particles by eukaryotic
cells.
J Virol
69
: 3258-3264.
28. Roden RBS, Weissinger EM, Henderson DW,
et al
. (1994) Neutraliza-
tion of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.
J Virol
68
: 7570-7574.
29. Giroglou T, Florin L, Schaefer F,
et al
. (2001) Human papillomavirus
infection requires cell surface heparan sulfate.
J Virol
75: 1565-1570.
30. Shafti-Karamat S, Handisurya A, Kriehuber E,
et al
. (2003) Different
heparan sulfate proteoglycans serve as cellular receptors for human papil-
lomaviruses.
J Virol
77
: 13125-13135.
31. Yang R, Yutzy IV WH, Viscidi RP, Roden RBS. (2003) Interaction of
L2 with b-actin directs intracellular transport of papillomavirus and
infection.
J Biol Chem
278
: 12546-12553.
32. Kawana Y, Kawana K, Yoshikawa H,
et al
. (2001) Human papillo-
mavirus type 16 minor capsid protein L2 N-terminal region containing
a common neutralization epitopre binds to the cell surface and enters
the cytoplasm.
J Virol
75
: 2331-2336.
33. Kawana K, Yoshikawa H, Taketani Y,
et al
. (1999) Common neutraliza-
tion epitope in minor capsid protein L2 of human papillomavirus types
16 and 6.
J Virol
73
: 6188-6190.
34. Yang R, Day PM, Yutzy IV WH,
et al
. (2003) Cell surface-binding motifs
of L2 that facilitate papillomavirus infection.
J Virol
77
: 3531-3541.
35. Giroglou T, Sapp M, Lane C,
et al
. (2001) Immunological analyses of
human papillomavirus capsids.
Vaccine
19
: 1783-1793.
36. Rose RC, Bonnez W, Rin CD,
et al
. (1994) Serological differentiation
of human papillomavirus types 11, 16 and 18 using recombinant virus-
like particles.
J Gen Virol
75
: 2445-2449.